BB Biotech (Switzerland) Technical Analysis

BION Stock  CHF 36.25  0.30  0.83%   
As of the 22nd of November, BB Biotech owns the Variance of 1.6, information ratio of (0.20), and Market Risk Adjusted Performance of 1.63. BB Biotech AG technical analysis gives you the methodology to make use of past data patterns to determine a pattern that approximates the direction of the entity's future prices. Please confirm BB Biotech AG coefficient of variation, variance, and the relationship between the mean deviation and standard deviation to decide if BB Biotech AG is priced fairly, providing market reflects its prevailing price of 36.25 per share.

BB Biotech Momentum Analysis

Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as BION, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to BION
  
BB Biotech's Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.
BB Biotech technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of BB Biotech technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of BB Biotech trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

BB Biotech AG Technical Analysis

Indicator
Time Period
Execute Indicator
The output start index for this execution was thirty-six with a total number of output elements of twenty-five. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of BB Biotech AG volatility. High ATR values indicate high volatility, and low values indicate low volatility.

BB Biotech AG Trend Analysis

Use this graph to draw trend lines for BB Biotech AG. You can use it to identify possible trend reversals for BB Biotech as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual BB Biotech price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.

BB Biotech Best Fit Change Line

The following chart estimates an ordinary least squares regression model for BB Biotech AG applied against its price change over selected period. The best fit line has a slop of   0.0046  , which may suggest that BB Biotech AG market price will keep on failing further. It has 122 observation points and a regression sum of squares at 0.81, which is the sum of squared deviations for the predicted BB Biotech price change compared to its average price change.

About BB Biotech Technical Analysis

The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of BB Biotech AG on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of BB Biotech AG based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on BB Biotech AG price pattern first instead of the macroeconomic environment surrounding BB Biotech AG. By analyzing BB Biotech's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of BB Biotech's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to BB Biotech specific price patterns or momentum indicators. Please read more on our technical analysis page.

BB Biotech November 22, 2024 Technical Indicators

Most technical analysis of BION help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for BION from various momentum indicators to cycle indicators. When you analyze BION charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

BB Biotech November 22, 2024 Daily Trend Indicators

Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as BION stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.

Additional Tools for BION Stock Analysis

When running BB Biotech's price analysis, check to measure BB Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BB Biotech is operating at the current time. Most of BB Biotech's value examination focuses on studying past and present price action to predict the probability of BB Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BB Biotech's price. Additionally, you may evaluate how the addition of BB Biotech to your portfolios can decrease your overall portfolio volatility.